[1] | Slavko K, Alison C, Ilya R. Potato protease inhibitors inhibit food intake and increase circulating cholecystokinin levels by a trypsin-dependent mechanism. Int J Obes (Lond) 2011; 35(2): 236–243. |
[2] | Imming P, Sinning C, Meyer A. Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov 2006;5:821–834. |
[3] | Cummings JH, Beatty ER, Kingman SM. Digestion and physiological properties of resistant starch in the human large bowel. British Journal of Nutrition. 1996;75:733 747. |
[4] | Corbett SW, Keesey RE. Energy balance of rats with lateral hypothalamic lesions. Am J Physiol 1982;242:E273-E279. |
[5] | Steffens AB, Strubbe JH, Balkan B, Scheurink JW. Neuroendocrinemechanisms involved in regulation of body weight, food intake and metabolism. Neurosci Biobehav Rev 1990;14:305-13. |
[6] | Flatt JP. Use and storage of carbohydrate and fat. Am J Clin Nutr 1995:61 Suppl:952S-959S. |
[7] | Jebb SA, Goldberg GR, Coward WA, Murgatroyd PR, Prentice AM. Effects of weight cycling caused by intermittent dieting on metabolic rate and body composition in obese women. Int J Obes. 1991;15:367-74. |
[8] | Hill AJ, Peikin SR, Ryan CA, Blundell JE. Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiol Behav. 1990;48: 241–246. |
[9] | Chang S. Am. J. Physiol. 259, R1096;1990. |
[10] | Richard DM. Effects of a combination fiber system on appetite and energy intake in overweight humans. Physiology & Behavior. 90;2007:705–711. |
[11] | West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol. 1984;246: R776–87. |
[12] | Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59:129–39. |
[13] | Burton-Freeman B. Dietary fiber and energy regulation. J Nutr. 2000;130:272S–5S. |
[14] | Slavin JL , Green H. Fibre and satiety. Nutr Bull . 2007;32(1):S32–S42. |
[15] | DiMeglio DP, Mattes RD. Liquid versus solid carbohydrate: effects on food intake and body weight. Int J Obes. 2000;24:794–800. |
[16] | Fujise T, Yoshimatsu H, Kurokawa M, Oohara A, Kang M, Nakata M. Satiation and masticatory function modulated by brain histamine in rats. PSEBM. 1998;217:228–34. |
[17] | Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004;126:432–40. |
[18] | Levine AS, Billington CJ. Appetite and Body Weight Regulation: Sugar, Fat, and Macronutrient Substitute. CRC Press: Boca Raton, FL. 1994. |
[19] | Institute of medicine, Food and Nutrition Board 2002 |
[20] | Davidson S, Passmore R. Human Nutrition and Dietetics (8th revised ed.). Philadelphia, PA: Churchill Livingstone. 1986; pp. 193–5. ISBN 978-0-443-02467-2. |
[21] | Englyst HN, Kingman SM, Cummings JH. Classification and measurement of nutritionally important starch fractions. Eur J Clin Nut, 1992;46:S33-50. |
[22] | Murphy MM, Douglass JS, Birkett A. Resistant starch intakes in the United States. J Am Diet Assoc. 2008;108:67-78. |
[23] | Higgins JA. Resistant starch: metabolic effects and potential health benefits. JAOAC. 2004;(3):761-8. |
[24] | Bodinham CL, Frost GS, Roberston MD. Acute ingestion of resistant starch reduces food intake in health adults. British Journal of Nutrition. 2010;103:917-922. |
[25] | Pi-Sunyer, FX. Glycemic index and disease. Am J Clin Nutr. 2002; 76(suppl):290S-298S. |
[26] | Schwartz JG, Guan D, Green GM, Phillips WT. Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients. Diabetes Care 1994; 17: 255–262. |
[27] | Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology. 1984; 87: 542–549. |
[28] | Louie DS, May D, Miller P, Owyang C. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol. 1986; 250: G252–G259. |
[29] | Fried M, Erlacher U, Schwizer W, Lochner C, Koerfer J, Beglinger C et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology. 1991; 101: 503–511. |
[30] | Padwal R, Kezouh A, Levine M, Etminan M. Long-term persistence with orlistat and sibutramine in a population- based cohort. Int J Obes (Lond) 2007; 31: 1567–1570. |
[31] | Al-salkhan MS, Howard LR, Miller JC. Antioxidant activity and total Phenolic in different genotypes of potato (Solanum tuberosum L.) Journal of Food Science. 1995;60:341-343. |
[32] | Dini I, Tenore GC, Dini A. Saponins in Ipomoea batatas L. tubers: Isolation, characterization, quantification and antioxidant properties. Food Chem. 2009;113:411–9. |
[33] | Carvalho IS, Cavaco T, Carvalho LM, Duque P. Effect of photoperiod on flavonoid pathway activity in Ipomoea batatas L. (Ipomoea batatas L. (Lam.)leaves. Food Chem. 2010;118:384–90. |
[34] | Rumbaoa RG, Cornago DF, Geronimo IM. Phenolic content and antioxidant capacity of Philippine Ipomoea batatas L. (Ipomoea batatas L.) varieties. Food Chem. 2009;113: 1133–8. |
[35] | Mendel Friedman. Chemistry, biochemistry, and dietary role of potato polyphenols. A Review. Journal of Agric. Food Chemistry. 1997;45(5):1523–1540. |
[36] | Nutrient data laboratory. United States Department of Agriculture. Accessed 27 July, 2012. Available at: http://www.nutrition-and-you.com/potato.html. |
[37] | Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983;54:275-287. |
[38] | Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. International Journal of Obesity. 2000;24:38–48. |
[39] | Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obesity Rev. 2005;6:297–306. |
[40] | Hu J, Edmonson B, Louie M, Dana S, Moore M, Radosevich J. The effectiveness of potato protease inhibitor II in promoting satiety in healthy human subjects (ISU trial). Kemin Health White Paper; 2004. |
[41] | Olubobokun TH, Aluko EO, Iyare EE, AnyaehieUB, Atang DE. Ipomoea batatas L. Extract Reduces Food Intake, Fasting Blood Glucose Levels and Body Weight. European Journal of Medicinal Plants 3(4): 530-539, 2013 |
[42] | Linda K. Butler. Regulation of blood glucose levels in normal and diabetic rats. 1995. |
[43] | Spreadbury D, Shao A, Essman M, Sheabar FS, Geletta S, Larsen B. A proteinase inhibitor extract from potatoes reduces post - prandial blood glucose in human subjects. JANA 2003;6:29-38. |
[44] | AFSSA (Agence Française de Sécurité Sanitaire des Aliments). Dietary fibre: definitions, analysis and nutrition claims. Specialist Expert Committee on Human Nutrition; 2002. |
[45] | Speigel TA, Hubert C, Peikin SR. Effect of a pre- meal beverage containing a protease inhibitor from potatoes on satiety in dieting overweight women. Presented at the North American Association for the study of obesity (NASSO) Annual Meeting. University of Medicine and Dentistry of New Jersey; 1999. |
[46] | Dana S. An Open label clinical trial to evaluate a satiety aid for overweight to obese, healthy adults. Kemin Health Technical Literature KCCTL-012-003. Appetite Control and Weight Loss; 2005. |
[47] | Liddle RA. Cholecystokinnin Cells. Annual Review of Physiology. 1997;59:221-242. |
[48] | Arora S. Role of neuropeptides in appetite regulation and obesity. Neuropeptides. 2006;40:375-401. |